LevelJump Announces 2025 First Quarter Results; Anticipates Revocation of Cease Trade Order

Rhea-AI Summary

LevelJump Healthcare Corp. reported strong Q1 2025 financial results with revenues of $4.58 million, representing a 12.8% increase from Q1 2024's $4.06 million. The company achieved a net profit of $200,566 and EBITDA of $898,017. Its subsidiary, Canadian Teleradiology Services, contributed $1.03 million in EBITDA. The company expects the revocation of a cease trade order after becoming current with disclosure obligations. Additionally, LevelJump has agreed to acquire two diagnostic imaging clinics in Calgary, with the deal expected to close in July 2025. The company anticipates trading reinstatement on the TSX Venture Exchange once the cease trade order is lifted.

Positive

• Revenue growth of 12.8% year-over-year to $4.58 million in Q1 2025
• Profitable quarter with net profit of $200,566
• Strong EBITDA of $898,017 in Q1 2025
• Strategic expansion through planned acquisition of two diagnostic imaging clinics in Calgary
• Company becoming current with disclosure obligations, leading to expected trading reinstatement

Negative

• Outstanding cease trade order currently restricting stock trading
• Company had fallen behind on continuous disclosure obligations

Toronto, Ontario--(Newsfile Corp. - June 23, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce its financial results for the three months ended March 31, 2025.

Financial and Operational Highlights

• Revenues were $4.58 million in the first quarter of 2025 compared to $4.06 million in the same period of 2024, a year over year revenue increase of 12.8%.

• Canadian Teleradiology Services, Inc., the Company's 100% owned subsidiary had EBITDA for the first quarter of 2025 of $1.03 million.

2025 First Quarter Financial Results

• Revenues of $4.58 million in Q1 2025 with a net profit of $200,566.
• EBITDA of $898,017 for Q1 2025.

Subsequent Events

Subsequent to the end of the quarter, the Company entered into an agreement to acquire two additional diagnostic imaging outpatient clinics located in Calgary, Alberta. The transaction is expected to close towards the end of July 2025. See the Company's news release dated June 13, 2025.

Management Comments

Mitch Geisler, CEO, commented, "We are very pleased with our strong Q1 results and year-over-year growth. Our focus will remain on driving revenue and enhancing profitability."

Company Anticipates Revocation of CTO

With the filing of its three month interim financial statements and related MD&A, the Company is now current with its continuous disclosure obligations. As a result, it is anticipated that the outstanding cease trade order issued by the Ontario Securities Commission will be revoked in the very near future at which time the Company's common shares will be eligible for reinstatement of trading on the TSX Venture Exchange (the "Exchange"). The Company has already made certain pre-filing submissions with the Exchange to ensure that trading resumes as soon as possible.

Non-IFRS Financial Measures

This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity.

For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Consolidated Financial Statements for the year ended December 31, 2024, which are available on the Company's website (www.leveljumphealthcare.com) and under the Company's profile on SEDAR (www.sedarplus.ca).

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler
Chief Executive Officer
info@leveljumphealthcare.com
647-340-2020

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/256482

FAQ

What were LevelJump Healthcare's (JMPHF) Q1 2025 revenue and profit figures?

LevelJump Healthcare reported Q1 2025 revenues of $4.58 million and a net profit of $200,566, with EBITDA of $898,017.

How much did LevelJump's revenue grow compared to Q1 2024?

LevelJump's revenue grew by 12.8%, increasing from $4.06 million in Q1 2024 to $4.58 million in Q1 2025.

What acquisitions is LevelJump Healthcare planning in 2025?

LevelJump has entered into an agreement to acquire two diagnostic imaging outpatient clinics in Calgary, Alberta, with the transaction expected to close in July 2025.

Why was LevelJump Healthcare under a cease trade order and when will it be lifted?

The cease trade order was issued due to delayed continuous disclosure obligations. The company expects it to be revoked soon as they are now current with their filings.

What was Canadian Teleradiology Services' EBITDA contribution in Q1 2025?

Canadian Teleradiology Services, LevelJump's wholly-owned subsidiary, contributed EBITDA of $1.03 million in Q1 2025.